en
Scientific article
Review
English

Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis

Published inAIDS, vol. 27, no. 7, p. 1135-1143
Publication date2013
Abstract

The risk of adverse drug events associated with nevirapine (NVP) is suggested to be greater in pregnant women. We conducted a systematic review and meta-analysis of severe adverse events in HIV-positive women who initiated NVP while pregnant.

Keywords
  • Adult
  • Anti-HIV Agents/administration & dosage/adverse effects
  • CD4 Lymphocyte Count
  • Female
  • HIV Seropositivity/drug therapy/immunology/transmission
  • Humans
  • Nevirapine/administration & dosage/adverse effects
  • Pregnancy
  • Pregnancy Complications, Infectious/drug therapy/immunology/virology
  • Risk Assessment
Research group
Citation (ISO format)
FORD, Nathan et al. Adverse events associated with nevirapine use in pregnancy: a systematic review and meta-analysis. In: AIDS, 2013, vol. 27, n° 7, p. 1135–1143. doi: 10.1097/QAD.0b013e32835e0752
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0269-9370
488views
0downloads

Technical informations

Creation12/03/2013 3:50:00 PM
First validation12/03/2013 3:50:00 PM
Update time03/14/2023 8:56:03 PM
Status update03/14/2023 8:56:03 PM
Last indexation01/16/2024 2:08:19 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack